Log in to save to my catalogue

Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors

Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4fe2b2d3f31846c4bbd1ef0fa6cfa982

Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors

About this item

Full title

Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-09, Vol.12 (1), p.16399-16399, Article 16399

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Malignant brain tumors consist of malignancies originated primarily within the brain and the metastatic lesions disseminated from other organs. In spite of intensive studies, malignant brain tumors remain to be a medical challenge. Patient-derived organoid (PDO) can recapitulate the biological features of the primary tumor it was derived from and h...

Alternative Titles

Full title

Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4fe2b2d3f31846c4bbd1ef0fa6cfa982

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4fe2b2d3f31846c4bbd1ef0fa6cfa982

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-20487-y

How to access this item